Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users
Frost & Sullivan
AUGUST 9, 2021
As life sciences companies aim to enhance patients’ treatment experiences and find new biomarkers that aid drug discovery, DTx companies diversify their pipelines by adding new indications, addressing unmet needs. billion in 2020, expanding exponentially at a compound annual growth rate (CAGR) of 29.8%. billion by 2025 from $1.23
Let's personalize your content